Associated Papers
Saturation mutagenesis identifies activating and resistance-inducing FGFR kinase domain mutations.
Tangermann C et al.
Nature Genetics, 2026
41361008 (PubMed )
Supplement: 41588_2025_2431_MOESM4_ESM.xlsx › Extended_data_figure_6a
A prospective, multicenter, comprehensive genomic profile signature study in patients with EGFR-mutant advanced non-small cell lung cancer at the first-line treatment failure of osimertinib.
Shi Y et al.
Signal Transduction and Targeted Therapy, 2025
41326340 (PubMed )
Supplement: 41392_2025_2481_MOESM1_ESM.docx
Expansion of the complex genotypic and phenotypic spectrum of FGFR2-associated neurocutaneous syndromes.
Schmidt J et al.
Human Genetics, 2024
Activating FGFR1 Mutations in Sporadic Pheochromocytomas.
Welander J et al.
World Journal of Surgery, 2018
Biophysical characterization of drug-resistant mutants of fibroblast growth factor receptor 1.
Yoza K et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms, 2016
Nuclear magnetic resonance analysis of the conformational state of cancer mutant of fibroblast growth factor receptor 1 tyrosine kinase domain.
Kobashigawa Y et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms, 2016
Select a paper to view details